1. Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells
    Ya-Hui Huang et al, 2019, Cells CrossRef
  2. Survivin in Breast Cancer: A Review
    Manuel Antonio Martínez-Sifuentes et al, 2022, Genetic Testing and Molecular Biomarkers CrossRef
  3. Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells
    Ewa Jasek-Gajda et al, 2019, Apoptosis CrossRef
  4. Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells
    Daniela León et al, 2020, International Journal of Molecular Sciences CrossRef
  5. A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity
    Shi Xu et al, 2022, Frontiers in Oncology CrossRef
  6. Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro
    Mª Jesús Núñez-Iglesias et al, 2021, International Journal of Molecular Sciences CrossRef
  7. B7-H3/CD276: An Emerging Cancer Immunotherapy
    Wu-Tong Zhou et al, 2021, Frontiers in Immunology CrossRef
  8. Antitumor Activity of Piceamycin by Upregulation of N-Myc Downstream-Regulated Gene 1 in Human Colorectal Cancer Cells
    Kay Zin Kyaw et al, 2022, Journal of Natural Products CrossRef
  9. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
    Navid Shomali et al, 2022, Frontiers in Immunology CrossRef
  10. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case–control studies
    Abdolkarim Moazeni-Roodi et al, 2019, International Journal of Clinical Oncology CrossRef
  11. Fenamates as Potential Therapeutics for Neurodegenerative Disorders
    Jaunetta Hill et al, 2021, Cells CrossRef
  12. The novel non‐immunological role and underlying mechanisms of B7‐H3 in tumorigenesis
    Xiangqi Zhou et al, 2019, Journal of Cellular Physiology CrossRef
  13. Anticancer activities of Brachydin C in human prostate tumor cells (DU145) grown in 2D and 3D models: Stimulation of cell death and downregulation of metalloproteinases in spheroids
    Larissa Cristina Bastos de Oliveira et al, 2022, Chemical Biology & Drug Design CrossRef
  14. Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
    Swaroop Kumar Pandey et al, 2022, Frontiers in Oncology CrossRef
  15. Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia Cells
    Ewa Jasek-Gajda et al, 2020, Antioxidants CrossRef
  16. Dominant-negative ATF5 rapidly depletes survivin in tumor cells
    Xiaotian Sun et al, 2019, Cell Death & Disease CrossRef
  17. Chemotherapy-Induced Survivin Regulation in Acute Myeloid Leukemia Cells
    Petra Otevřelová et al, 2021, Applied Sciences CrossRef
  18. Integrative Transcriptomic Network Analysis of Butyrate Treated Colorectal Cancer Cells
    Saira R. Ali et al, 2021, Cancers CrossRef
  19. Borealin-Derived Peptides as Survivin-Targeting Cancer Imaging and Therapeutic Agents
    Iori Nozaki et al, 2022, Bioconjugate Chemistry CrossRef
  20. Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line
    Behrouz Ebadi Sharafabad et al, 2023, Advanced Pharmaceutical Bulletin CrossRef
  21. New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
    Stephanie Jordaens et al, 2020, Cancer Immunology, Immunotherapy CrossRef